ChromaCode Stock

chromacode.comHealthcare / BioTech & PharmaFounded: 2012

ChromaCode is a biotechnology company that specializes in developing molecular diagnostics solutions. Founded in 2012 and headquartered in Carlsbad, California, the company's core technology is based on proprietary mathematical algorithms that enable the simultaneous detection of multiple DNA and RNA targets in a single reaction. ChromaCode harnesses the power of data science and advanced algorithms aiming to enhance the accuracy, efficiency, and affordability of diagnostic testing. Their solutions encompass infectious disease testing, genetic testing, oncology diagnostics, and more. The company works closely with clinical laboratories, healthcare providers, and regulatory agencies to ensure that their solutions meet rigorous quality standards and regulatory requirements.

Register for Details

For more details on financing and valuation for ChromaCode, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for ChromaCode.

Register Today

ChromaCode investors also invested in these private companies

Domain Associates
Windham Venture Partners
Global Brain
Okapi Venture Capital


Management Team

Mark McDonough
Chief Executive Officer
Aditya Rajagopal
PhD, Co-Founder and Chief Technical Officer
Padma Sundar
Chief Business Officer
Paul Flook
PhD, Chief Research and Development Officer
Chris MacDonald
PhD, Chief Scientific Officer

Board Members

Pat Smerkers
Northpond Ventures
Justin Klein
Vensana Capital
Jenny Yip
Adjuvant Capital

Other companies like ChromaCode in the BioTech & Pharma sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Updated on: Oct 3, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.